Sponsored Symposia Programme

Sponsored Symposia Programme

Please click on the below accordion to read the content of each section.

14:30 – 15:30

Shionogi Sponsored Symposium: Ospemifene: Can satisfaction and adherence impact clinical outcome of VVA treatment?

The management of Vulvo-Vaginal Atrophy (VVA) in menopausal women caused by physiological decline of oestrogen levels continues to evolve as new evidence and treatment strategies become available. In this symposium we aim to underline, through the exchanging of clinical experiences with ospemifene, the importance of patient’s satisfaction and adherence to treatment to obtain better therapeutic outputs. We also aim to share the emerging real-world evidence on the use of ospemifene to treat VVA as first-line treatment in menopausal women.

Chair: Santiago Palacios (Madrid, Spain)

14:30 – 14:40

Ospemifene: the only first-line oral treatment for women with moderate to severe VVA

Speaker: Santiago Palacios (Madrid, Spain)

14:40 – 14:55

Spanish real-world evidence on women satisfaction with VVA treatments in clinical practice: the CRETA study results

Speaker: Carmen Pingarron (Spain)

14:55 – 15:05

Italian real-world assessment of the use of oral and local treatment for moderate and severe VVA: the PEONY study

Speaker: Rossella Nappi (Italy)

15:05 – 15:25

Treating VVA in post-menopausal women with comorbidities in clinical practice


Santiago Palacios (Madrid, Spain)

Rossella Nappi (Italy)

Silvia Maffei (Pisa, Italy)

Tommaso Simoncini (Italy)

15:25 – 15:30

Closing remarks

Speaker: Santiago Palacios (Madrid, Spain)

15:45 – 16:45

Novo Nordisk Sponsored Symposium:  Obesity in Menopause: A paramount call to action for women´s health


The symposium will begin by introducing how obesity affects women throughout their life, with a deep focus on the physiopathology of obesity in menopause and perimenopause and the clinical management of obesity and overweight in menopause with present and future recommendations.


Chair: Santiago Palacios


Santiago Mayo (Medical Manager, Novo Nordisk Spain)

Rossella Nappi (Italy)

Peter Chedraui (Ecuador)

12:30 – 14:00

MYLAN ITALIA S.R.L. (Viatris) Sponsored Symposium: Doublepause: from pause to play

12:30 – 12:35


Speaker: Emmanuele A. Jannini

12:35 – 12:50

Doublepause: A New Paradigm in Treating Sexual Dysfunction

Speaker: Emmanuele A. Jannini

12:50 – 13:05

Female sex hormones and its role in desire and arousal

Speaker: Rossella Nappi (Italy)

13:05 – 13:20

Approach towards the couple from the gynecologist’s perspective

Speaker: Katrin Schaudig (Germany)

13:20 – 13:35

Couple-thinking: A new way of approaching sexual problems

Speaker: Anna Maria Giraldi

13:35 – 13:55

Fireside discussion and Q&A on taking a multi-disciplinary approach to Doublepause

Speakers: All

13:55 – 14:00

Closing remarks

Speaker: Emmanuele A. Jannini, Rossella Nappi (Italy)

12:30 – 14:00

Theramex Sponsored Symposium: Get ahead of the change – current menopause treatment navigation

Chair: Rossella Nappi (Italy)

12:30 – 12:40

From contraception through transition period to adopting an individualized approach for women in the management and treatment of menopause

Speaker: Rossella Nappi (Italy)

12:40 – 13:10

Could oral body-identical estradiol/micronized progesterone be the treatment option for all postmenopausal women?

Speaker: Petra Stute (Switzerland)

13:10 – 13:30

When transdermal treatment options are the right choice?

Speaker: Paula Briggs (United Kingdom)

13:30 – 13:55

When non-hormonal treatment is a choice: Menopause management with the natural selective estrogen receptor modulator DT56a

Speaker: Amos Ber (Israel)

13:55 – 14:00

Session closing

12:30 – 13:00


Fotona Sponsored Symposium: Vaginal erbium laser (VEL) for women in menopause


1.    VEL for improvement of GSM symptoms and sexual function
Speaker: Marco Gambacciani

2.    VEL for improvement of SUI
Speaker: Ivan Fistonić

3.    Laser treatment using intraurethral probe – What are the benefits?
Speaker: Tamer Erel